Biocon posts 9% operating revenue growth in Q3 FY26; EBITDA margin at 22%
● Feb 13, 2026
Biocon Limited (BSE: 532523 / NSE: BIOCON) reported consolidated operating revenue growth of 9% year-on-year for the quarter ended December...
